跳至主要内容
临床试验/DRKS00017381
DRKS00017381已完成4 期

Randomized, prospective, double-blind study to objectively demonstrate the performance and safety of the Rayocomp bioresonance device in patients with cervical spine disorder - R-HWS

Rayonex Biomedical GmbH0 个研究点目标入组 54 人开始时间: 2019年5月22日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1) Gender: male and female
  • 2) Age: at least 18 years
  • 3) At least moderate pain (= 5 on the VAS) in the cervical spine area
  • 4) Neck disabilty index with at least medium restriction (score = 15)
  • 5) Patients must be able to understand the patient information
  • 6) Patients must be willing and able to meet the requirements of the study
  • 7) Signed ICF

排除标准

  • 1) Systemic or inflammatory musculoskeletal disease (e.g., muscular dystrophies, polymyositis)
  • 2) Trauma with fractures and surgical treatment
  • 3) Severe systemic disease with a life expectancy <6 months (e.g., advanced heart failure, malignancies)
  • 4) Massive degenerative disease with marked restriction of motility (e.g., polyarthritis)
  • 5) Pregnant or breastfeeding female patients without effective contraception
  • 6) Patients who, due to mental illness, are unable to understand the study information, give their consent, or adhere to the study's guidelines
  • 7) Patients who, in the opinion of the investigator, are not suitable for the study
  • 8) Alcohol or drug abuse
  • 9) patients incapable of giving consent
  • 10) Persons who are in a dependency or employment relationship with the sponsor or investigator
  • 11) Detained persons
  • 12) Participation in another study

研究者

发起方
Rayonex Biomedical GmbH

相似试验

已完成
3 期
A study to compare 2 medications-Phenylephrine and Norepinephrine to prevent fall in blood pressure caused after giving spinal anaesthesia in patients undergoing Caesarean section.
CTRI/2020/03/023761AIIMS Raipur95
尚未招募
Unknown
Trial to assess efficacy of Curcunan® in the management of upper respiratory tract infectio
CTRI/2023/06/053472Dr. Willmar Schwabe India Pvt. Ltd.
尚未招募
不适用
use of melatonin to decrease the hemodynamic responses to laryngoscopy and intubatio
CTRI/2018/05/013835Sri Ramachandra University
进行中(未招募)
不适用
Prospective, randomized, double-blind study, placebo-controlled, parallel-group, multi-center trial assessing the effects of BF2.649 in treatment of excessive daytime sleepiness in narcolepsy (HARMONY I) - Harmony IarcolepsyMedDRA version: 9.1Level: LLTClassification code 10028713Term: NarcolepsyMedDRA version: 9.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedMedDRA version: 9.1Level: LLTClassification code 10021235Term: Idiopathic narcolepsyMedDRA version: 9.1Level: LLTClassification code 10007737Term: CataplexyMedDRA version: 9.1Level: LLTClassification code 10048323Term: Cataplexy aggravated
EUCTR2008-007866-46-DEBioprojet90
进行中(未招募)
不适用
Prospective, randomized, double-blind study, placebo-controlled, parallel-group, multi-center trial assessing the effects of BF2.649 in treatment of excessive daytime sleepiness in narcolepsy. - Harmony IarcolepsyMedDRA version: 9.1Level: LLTClassification code 10028713Term: NarcolepsyMedDRA version: 9.1Level: LLTClassification code 10048322Term: Narcolepsy aggravatedMedDRA version: 9.1Level: LLTClassification code 10021235Term: Idiopathic narcolepsyMedDRA version: 9.1Level: LLTClassification code 10007737Term: CataplexyMedDRA version: 9.1Level: LLTClassification code 10048323Term: Cataplexy aggravated
EUCTR2008-007866-46-NLBioprojet90